Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions

Cardiovascular Research
Tim KinnairdS E Epstein

Abstract

Animal and early clinical studies of gene therapy for tissue ischaemia suggested that this approach might provide benefit to patients with coronary artery disease not amenable to traditional revascularization. This enthusiasm was then tempered by the subsequent disappointing results of randomized clinical trials and led researchers to develop strategies using progenitor cells as an alternative to improve collateral function. However, the recent publication of several randomized clinical trials reporting either negative or weakly positive results using this approach have led to questions regarding its effectiveness. There are several factors that need to be considered in explaining the discordance between the positive studies of such treatments in animals and the disappointing results seen in randomized patient trials. Aside from the practical issues of arteriogenic therapies, such as effective delivery, vascular remodelling is an extraordinarily complex process, and the administration of a single agent or cell in the hope that it would lead to lasting physiological effects may be far too simplistic an approach. In addition, however, evidence now suggests that many of the traditional cardiovascular risk factors-such as age and h...Continue Reading

Citations

Feb 14, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Gabor M Rubanyi
May 14, 2011·Journal of Applied Physiology·Cristine L Heaps, Janet L Parker
Jun 17, 2010·Physiological Genomics·Dan Chalothorn, James E Faber
Mar 30, 2011·European Journal of Clinical Pharmacology·Francesco CacciatoreClaudio Napoli
Dec 4, 2010·Atherosclerosis·Claudio NapoliLouis J Ignarro
Feb 26, 2016·Free Radical Biology & Medicine·Hiroyuki YamauchiYasuchika Takeishi
Jun 17, 2008·Trends in Cardiovascular Medicine·Navin K Kapur, Jeffrey J Rade
Aug 28, 2009·Journal of Cellular Biochemistry·Erica B SneiderLouis M Messina
Nov 4, 2010·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Joshua K Meisner, Richard J Price
Feb 10, 2010·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Matthew A ZieglerJoseph L Unthank
Jun 27, 2012·Circulation·Stephen E EpsteinMary Susan Burnett
Sep 5, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Joshua L HeusleinRichard J Price
Aug 25, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Matthew R DiStasiJoseph L Unthank

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.